1. Home
  2. ALLO vs GASS Comparison

ALLO vs GASS Comparison

Compare ALLO & GASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLO
  • GASS
  • Stock Information
  • Founded
  • ALLO 2017
  • GASS 2004
  • Country
  • ALLO United States
  • GASS Greece
  • Employees
  • ALLO N/A
  • GASS N/A
  • Industry
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • GASS Marine Transportation
  • Sector
  • ALLO Health Care
  • GASS Consumer Discretionary
  • Exchange
  • ALLO Nasdaq
  • GASS Nasdaq
  • Market Cap
  • ALLO 252.9M
  • GASS 243.4M
  • IPO Year
  • ALLO 2018
  • GASS 2005
  • Fundamental
  • Price
  • ALLO $1.21
  • GASS $6.50
  • Analyst Decision
  • ALLO Buy
  • GASS
  • Analyst Count
  • ALLO 12
  • GASS 0
  • Target Price
  • ALLO $8.80
  • GASS N/A
  • AVG Volume (30 Days)
  • ALLO 2.9M
  • GASS 107.6K
  • Earning Date
  • ALLO 11-13-2025
  • GASS 11-24-2025
  • Dividend Yield
  • ALLO N/A
  • GASS N/A
  • EPS Growth
  • ALLO N/A
  • GASS N/A
  • EPS
  • ALLO N/A
  • GASS 1.64
  • Revenue
  • ALLO N/A
  • GASS $173,172,375.00
  • Revenue This Year
  • ALLO N/A
  • GASS $2.45
  • Revenue Next Year
  • ALLO $100.00
  • GASS N/A
  • P/E Ratio
  • ALLO N/A
  • GASS $3.97
  • Revenue Growth
  • ALLO N/A
  • GASS 13.82
  • 52 Week Low
  • ALLO $0.86
  • GASS $4.82
  • 52 Week High
  • ALLO $3.78
  • GASS $8.18
  • Technical
  • Relative Strength Index (RSI)
  • ALLO 49.04
  • GASS 47.32
  • Support Level
  • ALLO $1.21
  • GASS $6.48
  • Resistance Level
  • ALLO $1.26
  • GASS $6.69
  • Average True Range (ATR)
  • ALLO 0.08
  • GASS 0.18
  • MACD
  • ALLO -0.01
  • GASS 0.04
  • Stochastic Oscillator
  • ALLO 14.18
  • GASS 70.18

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About GASS StealthGas Inc.

StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.

Share on Social Networks: